Muirwoods Ventures

Muirwoods Ventures is a venture capital firm established in 2020 and based in Seoul, South Korea. The firm specializes in investments in information technology and bio-healthcare, with a strong emphasis on sustainability and mass-market appeal. Muirwoods Ventures targets sectors such as healthcare, technology, mobility, and environmental solutions, aiming to support innovations that can positively impact diverse populations.

Kyoungmi Kim

Vice President and Partner

Jeong-ah Ryou

Co-Founder and CEO

HanJoon Song

Investment Principal

10 past transactions

Best Innovation

Seed Round in 2025
Best Innovation is a manufacturer specializing in cosmetic products. Its mission is to provide safe alternatives to potentially harmful skincare chemicals. The company produces products composed mainly of comfortable, organic ingredients, free from controversial substances, offering customers a healthier beauty option.

Bazbiomedic

Series B in 2024
Bazbiomedic primarily focuses on offering an automatic repeat injection needle-less drug delivery device for the skin and beauty device.

Eight Tech

Series A in 2023
Eight Tech is a resource circulation platform that solves the waste problem with science and technology.

InhandPlus

Series A in 2023
InhandPlus is a company focused on addressing the issue of medical nonadherence, where patients fail to follow prescribed treatment plans, often leading to significant health risks and increased healthcare costs. The company has developed a proprietary smartwatch that automatically tracks medication usage, providing insights into when and what medications users take. This data is analyzed through an AI-based management platform, which offers personalized healthcare services tailored to individual needs. InhandPlus aims to create reliable real-world healthcare data and enhance patient engagement, particularly for individuals with chronic diseases, mental health conditions, and the elderly. By leveraging wearable technology, InhandPlus seeks to streamline medication management and improve overall healthcare outcomes.

Kodiak Robotics

Series B in 2021
Kodiak Robotics, Inc. is a technology company focused on developing autonomous systems specifically for long-haul trucking. Founded in 2018 and headquartered in Mountain View, California, the company specializes in autonomous vehicles, information technology, software, logistics, and robotics. Kodiak Robotics designs self-driving trucks that are capable of operating on highway routes, employing advanced sensor fusion systems and lightweight mapping techniques. By enabling vehicles to manage all aspects of highway driving, Kodiak aims to enhance operational efficiency and reduce costs for businesses in the logistics sector.

Crowdworks

Series C in 2021
CrowdWorks, Inc. is a South Korea-based company that operates an online crowdsourcing platform specifically designed for artificial intelligence (AI). The company focuses on enhancing machine learning processes by collecting, structuring, and strengthening training data. It provides services that include the analysis and classification of various types of data, such as images, text, audio, and survey responses. By utilizing a pool of approximately 500,000 qualified labelers, CrowdWorks aims to improve the accuracy of human-powered data, thereby streamlining the AI model training workflow. The platform's Auto-ML features facilitate efficient data preparation, making it an essential resource for over 430 leading AI companies seeking to rapidly develop and deploy advanced AI solutions.

Gatik

Series B in 2021
Gatik is a startup focused on developing autonomous technology for light and medium-duty trucks aimed at B2B short-haul logistics. Founded in 2017 and headquartered in Mountain View, California, the company specializes in artificial intelligence and automotive technology. Gatik's software is designed to facilitate SAE Level 4 autonomy for commercial vehicles, specifically Class 3 to Class 7 trucks and vans. This technology is tailored for middle-mile logistics, allowing customers to efficiently meet scheduled delivery requirements.

LISCure Biosciences

Series B in 2020
LISCure Biosciences Co., Ltd. is a biotechnology company based in Seoul, South Korea, established in 2018. The company specializes in researching and developing bacteria-mediated immunotherapy aimed at treating a range of medical conditions, including tumors, degenerative neurological diseases, autoimmune diseases, and metabolic diseases. LISCure Biosciences currently has seven therapeutic pipelines and two pipelines focused on health-functioning food, with plans to explore the introduction of additional pipelines. Through its innovative approaches, the company seeks to enhance treatment options for healthcare professionals and improve patient outcomes in various disease categories.

Gatik

Series A in 2020
Gatik is a startup focused on developing autonomous technology for light and medium-duty trucks aimed at B2B short-haul logistics. Founded in 2017 and headquartered in Mountain View, California, the company specializes in artificial intelligence and automotive technology. Gatik's software is designed to facilitate SAE Level 4 autonomy for commercial vehicles, specifically Class 3 to Class 7 trucks and vans. This technology is tailored for middle-mile logistics, allowing customers to efficiently meet scheduled delivery requirements.

Curiox Biosystems

Series B in 2019
Curiox Biosystems Pte. Ltd. is a bioinstrumentation company that specializes in the development and commercialization of innovative assay platforms aimed at advancing the life sciences, drug discovery, and diagnostics. Established in 2007 and headquartered in Singapore, Curiox offers a range of products designed to enhance the efficiency and automation of bioassays, including DropArray microplates for miniaturized assays and Laminar Wash technology for automated cell processing. Its product lineup includes various washing stations, microplates, fluids, and accessories tailored for applications such as bead-based immunoassays, suspension cell assays, high-content assays, and iPS cell research. Leveraging expertise in surface chemistry and engineering, Curiox is committed to overcoming challenges in life science research through improved automation and reproducibility.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.